HDAC9 and stroke disorder: With this regard, the study performed by Brookes et al. [22] emphasizes the importance of HDAC9 in the pathogenesis of stroke, as well as the possible positive effect of using sodium valproate (as a non-selective HDAC9 inhibitor) in reducing the recurrence rate of stroke (p = 0.002) [19].